Cargando…
Novel treatments for congenital adrenal hyperplasia
Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD) need life-long medical treatment to replace the lacking glucocorticoids and potentially lacking mineralocorticoids and to lower elevated adrenal androgens. Long-term complications are common, including gona...
Autores principales: | Schröder, Mariska A. M., Claahsen - van der Grinten, Hedi L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156475/ https://www.ncbi.nlm.nih.gov/pubmed/35199280 http://dx.doi.org/10.1007/s11154-022-09717-w |
Ejemplares similares
-
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
por: Adriaansen, Bas P. H., et al.
Publicado: (2022) -
Testicular Adrenal Rest Tumours in Congenital Adrenal Hyperplasia
por: Claahsen-van der Grinten, H. L., et al.
Publicado: (2009) -
Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population
por: Sanches, Sarita A, et al.
Publicado: (2012) -
Body Image and Quality of Life in Women with Congenital Adrenal Hyperplasia
por: Tschaidse, Lea, et al.
Publicado: (2022) -
PMON191 Current Management of Acute Adrenal Insufficiency Related Adverse Events in Children with Congenital Adrenal Hyperplasia- Results of an International Survey of Specialist Centres
por: Ali, Salma Rashid, et al.
Publicado: (2022)